skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

54 studies were found about rifampin

Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00620438

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00411996

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00483054

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00000641

Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

Condition: HIV Infection; Pulmonary TB

NCT ID: NCT00933790

Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00617643

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV

Condition: HIV Infection; Tuberculosis

NCT ID: NCT01601626

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000636

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000638

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00822315

Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00096850

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01138202

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00476853

Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB

Condition: HIV/TB Co-infection

NCT ID: NCT01805258

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

Condition: Opioid Dependency; HIV Infections

NCT ID: NCT00877591

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000950

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

Condition: Tuberculosis; Aids; Hiv Infections

NCT ID: NCT00495326

A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00402610

Immune Activation and Drug Absorption in HIV-Infected Patients

Condition: HIV Infection

NCT ID: NCT01845298

Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00802802

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00771498

The Treatment of Tuberculosis in HIV-Infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00001033

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00000796

Rifampin and Efavirenz Interactions in Older Children

Condition: HIV; Tuberculosis

NCT ID: NCT01704144

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Tuberculosis

NCT ID: NCT00698334

Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00533390

Rifampin and Nevirapine Interactions in Young Children

Condition: Tuberculosis; HIV

NCT ID: NCT01699633

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3

Condition: HIV-1 Infection

NCT ID: NCT02057796

Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis

Condition: Tuberculosis; Human Immunodeficiency Virus Infections

NCT ID: NCT00376012

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment

Condition: HIV Infection

NCT ID: NCT01380080

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Condition: HIV Infections

NCT ID: NCT00402454

Tuberculosis Prevention for HIV Infected Adults

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00057122

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Condition: AIDS; Tuberculosis

NCT ID: NCT01700790

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01231542

Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

Condition: Tuberculosis; HIV Infections

NCT ID: NCT00474435

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana

Condition: Tuberculosis; HIV

NCT ID: NCT01687504

The Effect of Intermittent Rifampicin on Raltegravir

Condition: HIV; Tuberculosis

NCT ID: NCT01424826

Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis

Condition: Acquired Immunodeficiency Syndrome; Tuberculosis

NCT ID: NCT01315301

Evaluating the Safety, Tolerance, Drug Interactions, and Effective Dosing of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in ART-Naive Children Infected With HIV and TB

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01751568

A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00523458

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

Condition: Tuberculosis; HIV

NCT ID: NCT01637558

Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects

Condition: Tuberculosis

NCT ID: NCT01587469

Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes

Condition: AIDS With Tuberculosis

NCT ID: NCT01782950

Durability of Nevirapine-Based Antiretroviral Regimen

Condition: HIV Infections

NCT ID: NCT00703898

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Condition: HIV; Tuberculosis

NCT ID: NCT01663168

Tuberculosis Treatment Shortening Trial

Condition: Tuberculosis

NCT ID: NCT00130247

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00651066

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00640887

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Condition: HIV Infections

NCT ID: NCT00042289

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00108862

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

Condition: Mycobacterium Avium-Intracellulare Infection; HIV Infections

NCT ID: NCT00002192

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Condition: Tuberculosis

NCT ID: NCT01222338

Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients

Condition: Tuberculosis

NCT ID: NCT01690403

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine

Condition: Tuberculosis

NCT ID: NCT00023387